Volumes : Issues : Articles

Cancer Watch 2000
Cancer Watch 2001
Cancer Watch 2002
Cancer Watch 2003
Cancer Watch 2004
Cancer Watch 2005
Cancer Watch 2006
Cancer Watch 2007
Cancer Watch 2008
Cancer Watch 2009
Cancer Watch 2010
Cancer Watch 2011
Cancer Watch 2012

CW July 2005

Volume 14
Issue Number 7
July 2005
ISSN 10593802

Adjuvant Chemotherapy with Gemcitabine Delays Recurrence in Resectable Pancreatic Cancer

Gemcitabine may become the standard of care for adjuvant treatment of pancreatic cancer, according to a new study that shows the drug significantly delays recurrence in resectable pancreatic cancer.
Go to Previous Page
Go to Next Page

Source & Additional Reading

P. Neuhaus, 41st Annual Meeting of the American Society of Clinical Oncology.

Purchase Downloadable Full-text PDF of Article: $10.00

Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details.

Download Complete Issue CW July 2005

Purchase Downloadable Full-text PDF of Complete Issue: $20.00

<< Go Back to CW July 2005